Solid Biosciences (SLDB) Current Leases: 2018-2024
Historic Current Leases for Solid Biosciences (SLDB) over the last 6 years, with Sep 2024 value amounting to $1.7 million.
- Solid Biosciences' Current Leases fell 6.98% to $1.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year decrease of 6.98%. This contributed to the annual value of $1.9 million for FY2023, which is 2.21% down from last year.
- As of Q3 2024, Solid Biosciences' Current Leases stood at $1.7 million, which was down 0.35% from $1.7 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Current Leases registered a high of $2.0 million during Q4 2020, and its lowest value of $412,000 during Q2 2022.
- For the 3-year period, Solid Biosciences' Current Leases averaged around $1.5 million, with its median value being $1.7 million (2024).
- In the last 5 years, Solid Biosciences' Current Leases crashed by 72.52% in 2022 and then spiked by 349.76% in 2023.
- Quarterly analysis of 5 years shows Solid Biosciences' Current Leases stood at $2.0 million in 2020, then tumbled by 36.82% to $1.3 million in 2021, then soared by 50.20% to $1.9 million in 2022, then decreased by 2.21% to $1.9 million in 2023, then decreased by 6.98% to $1.7 million in 2024.
- Its Current Leases was $1.7 million in Q3 2024, compared to $1.7 million in Q2 2024 and $1.7 million in Q1 2024.